Immunogenicity of an aav-based covid-19 vaccine in murine models of obesity and aging

HIGHLIGHTS

• who: Dawid Maciorowski and colleagues from the Department of Ophthalmology, Ocular Genomics Institute, Harvard Medical School, Boston, MA, USA Harvard Stem Cell Institute, Harvard University, Cambridge, MA, USA have published the Article: Immunogenicity of an AAV-Based COVID-19 Vaccine in Murine Models of Obesity and Aging, in the Journal: Viruses 2022, 820 of 13/04/2022
• what: For the studies , the authors evaluated the immune_response of the experimental AAV-based COVID-19 vaccines against murine models of obesity and aging, with the prior understanding of the real-life limitations of murine models. The authors . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.